(Q42527574)
Statements
Silybin-beta-cyclodextrin in the treatment of patients with diabetes mellitus and alcoholic liver disease. Efficacy study of a new preparation of an anti-oxidant agent (English)
Lirussi F
Beccarello A
Zanette G
De Monte A
Donadon V
Velussi M
1 August 2002